Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

HIV Infection

Free Subscription Articles published in Antimicrob Agents Chemother Retrieve available abstracts of 81 articles: HTML format

Single Articles

July 2008
1. JIN H , Siwak EB, Smith R, Liwang PJ, et al
   Very strong synergy between modified RANTES and gp41 binding peptides leads to potent anti-HIV-1 activity.
   Antimicrob Agents Chemother. 2008.
   PubMed     Related articles    Abstract available
   
   
   
2. ABDURAHMAN S , Vegvari A, Youssefi M, Levi M, et al
   Anti-HIV Activity of the Small Modified Amino Acid {alpha}-Hydroxy Glycineamide on In Vitro and In Vivo HIV-1 Capsid Assembly and Infectivity.
   Antimicrob Agents Chemother. 2008.
   PubMed     Related articles    Abstract available
   
   
   
3. MARCELIN AG , Masquelier B, Descamps D, Izopet J, et al
   Tipranavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. SHUCK-LEE D , Chen FF, Willard R, Raman S, et al
   Identification of Heterocyclic Compounds that Inhibit Rev-RRE Function and Human Immunodeficiency Virus Type-1 Replication.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. WENNING LA , Friedman EJ, Kost JT, Breidinger SA, et al
   Lack of a significant drug interaction between raltegravir and tenofovir.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. ROBBINS BL , Capparelli EV, Chadwick EG, Yogev R, et al
   Pharmacokinetics of High-Dose Lopinavir/Ritonavir with and without Saquinavir or Non-Nucleoside Reverse Transcriptase Inhibitors in HIV Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors - Study PACTG P1038.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   June 2008
7. WANG G , Watson KM, Buckheit RW Jr
   Anti-HIV-1 Activity of Antimicrobial Peptides Derived from Human and Bovine Cathelicidins.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. ZAHM JA , Bera S, Pandey KK, Vora A, et al
   Mechanisms of Human Immunodeficiency Virus Type-1 Concerted Integration as related to Strand Transfer Inhibition and Drug Resistance.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. SCHULBIN H , Bode H, Stocker H, Schmidt W, et al
   Cytokine expression in the colonic mucosa of HIV-infected individuals before and during nine months of antiretroviral therapy.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. VAN ROMPAY KK , Durand-Gasselin L, Brignolo LL, Ray AS, et al
    Chronic administration of tenofovir to rhesus macaques from infancy throughout adulthood and pregnancy: summary of pharmacokinetics, biological and virological effects.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. DICENZO R , Peterson DR, Cruttenden K, Mariuz P, et al
    Effects of Minocycline and Valproic acid Coadministration on Atazanavir Plasma Concentrations in HIV-infected Adults Receiving Atazanavir/Ritonavir.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. PINNA D , Oreste P, Coradin T, Kajaste-Rudnitski A, et al
    Inhibition of Herpes Simplex Virus Type 1 and 2 In Vitro Infection by Sulfated Derivatives of K5 Escherichia coli Polysaccharide.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. WATSON KM , Buckheit CE, Buckheit RW Jr
    Comparative Evaluation of Virus Transmission Inhibition by Dual-Acting Pyrimidinedione Microbicides Using the Microbicide Transmission and Sterilization Assay (MTSA).
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. SAITOH A , Haas R, Naviaux R, Salva NG, et al
    Impact of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on Mitochondrial DNA and RNA in Human Skeletal Muscle Cells.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. HOMBROUCK A , Van Remoortel B, Michiels M, Noppe W, et al
    Preclinical evaluation of 1H-benzylindole derivatives as novel HIV integrase strand transfer inhibitors.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    May 2008
16. STANKOV MV , Schmidt RE, Behrens GM
    Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. TERRAZAS-ARANDA K , Van Herrewege Y, Hazuda D, Lewi P, et al
    HIV-1 Integration: A Potential Target for Microbicides to Prevent Cell-free or Cell-associated Human Immunodeficiency Virus type-1 Infection.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    April 2008
18. LEK-UTHAI U , Suwanarusk R, Ruengweerayut R, Skinner-Adams TS, et al
    HIV-1 protease inhibitors and clinical isolates of Plasmodium: Greater activity against P. vivax than P. falciparum.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. FRANSEN S , Bridger G, Whitcomb JM, Toma J, et al
    Suppression of Dual-Tropic HIV-1 by the CXCR4 Antagonist AMD3100 is Associated with Efficiency of CXCR4 Use and Baseline Virus Composition.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. DURAND-GASSELIN L , Pruvost A, Dehee A, Vaudre G, et al
    High levels of AZT and its intracellular phosphate metabolites in AZT and AZT/3TC-treated newborns of HIV-infected mothers.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. ENDIMIANI A , Carias LL, Hujer AM, Bethel CR, et al
    Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae possessing blaKPC in the United States.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. VON HENTIG N , Kaykhin P, Stephan C, Babacan E, et al
    Decrease of atazanavir and lopinavir plasma concentrations in a boosted double HIV-protease inhibitor salvage regimen.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. ZHU M , Bifano M, Xu X, Wang Y, et al
    Lack of an Effect of HIV Co-Infection on the Pharmacokinetics of Entecavir in HBV Infected Patients.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. YANG G , Wang J, Cheng Y, Dutschman GE, et al
    Mechanism of Inhibition of HIV-1 Reverse Transcriptase by a Stavudine Analogue 4'-Ethynyl-D4TTP.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. AKKARAWONGSA R , Potocky TB, English E, Gellman SH, et al
    INHIBITION OF HERPES SIMPLEX VIRUS TYPE 1 INFECTION BY CATIONIC {beta}-PEPTIDES.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
26. HOMBROUCK A , Voet A, Van Remoortel B, Desadeleer C, et al
    Mutations in HIV-1 Integrase Confer Resistance to the Naphthyridine L-870,810 and Cross Resistance to the Clinical Trial drug GS-9137.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. NAKATA H , Steinberg SM, Koh Y, Maeda K, et al
    Potent synergistic anti-HIV effects using combinations of a CCR5 inhibitor aplaviroc with other anti-HIV drugs.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. TELESHOVA N , Chang T, Profy A, Klotman ME, et al
    Inhibitory effect of PRO 2000, a candidate microbicide, on dendritic cell - mediated HIV transfer.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. KIM MJ , Jardel C, Barthelemy C, Jan V, et al
    Mitochondrial DNA content: an inaccurate biomarker of mitochondrial alteration in HIV-related lipodystrophy.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. LACKMAN-SMITH C , Osterling C, Luckenbaugh K, Mankowski M, et al
    Development of a Comprehensive Human Immunodeficiency Virus Type 1 (HIV-1) Screening Algorithm for Discovery and Preclinical Testing of Topical Microbicides.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. LIN PF , Nowicka-Sans B, Terry B, Zhang S, et al
    Entecavir Exhibits Inhibitory Activity Against HIV Under Conditions of Reduced Viral Challenge.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. RABAAOUI S , Zouhiri F, Lancon A, Leh H, et al
    Inhibitors of strand transfer that prevent integration and inhibit HTLV-1 early replication.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
33. BARRAIL-TRAN A , Morand-Joubert L, Poizat G, Raguin G, et al
    Predictive value of the HIV phenotype and genotype and of amprenavir and lopinavir inhibitory quotients in heavily pretreated patients on a ritonavir-boosted dual protease inhibitor regimen.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
34. CAO YJ , Flexner CW, Dunaway S, Park JG, et al
    Effect of Low-dose Ritonavir on the Pharmacokinetics of the CXCR4 Antagonist AMD070 in Healthy Volunteers.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
35. KHARASCH ED , Mitchell D, Coles R, Blanco R, et al
    Rapid clinical induction of hepatic cytochrome P4502B6 (CYP2B6) activity by ritonavir.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
36. GHOSN J , De Montgolfier I, Cornelie C, Dominguez S, et al
    Antiretroviral therapy with indinavir 400 mg-ritonavir 100 mg twice daily containing regimen in HIV-1 infected women during pregnancy.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
37. DESBOIS D , Roquebert B, Peytavin G, Damond F, et al
    In vitro Phenotypic Susceptibility of HIV-2 Clinical Isolates to Protease Inhibitors.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
38. MALET I , Delelis O, Valantin MA, Montes B, et al
    Mutations Associated with Failure of Raltegravir Treatment affect integrase sensitivity to the inhibitor in vitro.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. DEKHTYAR T , Ng TI, Lu L, Masse S, et al
    Characterization of a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, A-790742.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
40. PTAK RG , Gallay PA, Jochmans D, Halestrap AP, et al
    Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
41. GARVEY EP , Johns BA, Gartland MJ, Foster SA, et al
    The Naphthyridinone GSK364735 Is A Novel, Potent Human Immunodeficiency Virus-1 Integrase Inhibitor And Antiretroviral.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. NUTTALL JP , Thake DC, Lewis MG, Ferkany JW, et al
    Concentrations of Dapivirine in the Rhesus Macaque and Rabbit Following Once Daily Intravaginal Administration of a Gel Formulation of [14C]Dapivirine for 7 Days.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. BORKOW G , Lara HH, Covington CY, Nyamathi A, et al
    Deactivation of HIV-1 in Medium by Copper-Oxide Containing Filters.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. TANAKA R , Hanabusa H, Kinai E, Hasegawa N, et al
    Intracellular Efavirenz Levels in Peripheral Blood Mononuclear Cells from HIV-Infected Individuals.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
45. NICHOLS WG , Steel HM, Bonny T, Adkison K, et al
    Hepatotoxicity observed in clinical trials of aplaviroc (873140).
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. NAGULESWARAN A , Fialho AM, Chaudhari A, Hong CS, et al
    Azurin-like protein blocks invasion of Toxoplasma gondii through potential interactions with parasite surface antigen SAG1.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
47. CIHLAR T , Ray AS, Boojamra CG, Zhang L, et al
    Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant HIV-1 variants, and its orally bioavailable phosphonoamidate prodrug GS-9131.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. RAY AS , Vela JE, Boojamra CG, Zhang L, et al
    Intracellular Metabolism of the Nucleotide Prodrug GS-9131 a Potent Anti-HIV Agent.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. FORD SL , Chen YC, Lou Y, Borland J, et al
    Pharmacokinetic Interaction between Fosamprenavir/Ritonavir and Rifabutin in Healthy Subjects.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
50. LAMBERT-NICLOT S , Flandre P, Canestri A, Peytavin G, et al
    Factors associated with the selection of mutations conferring resistance to protease inhibitors in PI-experienced patients displaying treatment failure on darunavir.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. KISER JJ , Fletcher CV, Flynn PM, Cunningham CK, et al
    Pharmacokinetics of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate and Atazanavir/Ritonavir in Adolescents and Young Adults with HIV Infection - Study ATN056.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. HANES JW , Johnson KA
    Exonuclease Removal of Dideoxycytidine (Zalcitabine) by the Human Mitochondrial DNA Polymerase.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    October 2007
53. BALESTRIERI E , Matteucci C, Ascolani A, Piperno A, et al
    Effect of phosphonated carbocyclic 2'-oxa-3'-aza-nucleoside on HTLV-1 infection in vitro.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
54. SMITH RA , Gottlieb GS, Anderson DJ, Pyrak CL, et al
    HIV-1 and HIV-2 Exhibit Comparable Sensitivity to AZT and Other Nucleoside Analog Inhibitors In Vitro.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
55. MARCHAND C , Beutler JA, Wamiru A, Budihas S, et al
    Madurahydroxylactone derivatives as dual inhibitors of HIV-1 integrase and RNase H.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
56. BUCKHEIT RW JR , Hartman TL, Watson KM, Chung SG, et al
    Comparative Evaluation of the Inhibitory Activity of a Series of Pyrimidinedione Congeners Which Inhibit Both HIV-1 and HIV-2.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
57. ZELINA S , Sheen CW, Radzio J, Mellors JW, et al
    MECHANISMS BY WHICH G333D IN HIV-1 REVERSE TRANSCRIPTASE FACILITATES DUAL RESISTANCE TO ZIDOVUDINE (AZT) AND LAMIVUDINE (3TC).
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
58. LAI W , Huang L, Ho P, Li Z, et al
    Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of HIV-1.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
59. STAIB P , Lermann U, Blass-Warmuth J, Degel B, et al
    Tetracycline-inducible expression of individual Secreted Aspartic Proteases in Candida albicans allows isoenzyme-specific inhibitor screening.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
60. REDDY YS , Min SS, Borland J, Song I, et al
    Safety and Pharmacokinetics of GSK364735, an HIV-1 Integrase Inhibitor, Following Single and Repeat Administration in Healthy Adult Subjects.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
61. RODRIGUEZ-TUDELA JL , Almirante B, Rodriguez-Pardo D, Laguna F, et al
    Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.
    Antimicrob Agents Chemother. 2007;51:3599-604.
    PubMed     Related articles    Abstract available
    
    
    
62. LIU P , Foster G, Gandelman K, LaBadie RR, et al
    Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects.
    Antimicrob Agents Chemother. 2007;51:3617-26.
    PubMed     Related articles    Abstract available
    
    
    September 2007
63. SAITOH A , Fenton T, Alvero C, Fletcher CV, et al
    Impact of Nucleoside Reverse Transcriptase Inhibitors on Mitochondria in HIV-1 Infected Children Receiving HAART.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
64. TREMOULET AH , Capparelli EV, Patel P, Acosta EP, et al
    Population Pharmacokinetics of Lamivudine in HIV Exposed and Infected Infants.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
65. BRADSHAW D , Malik S, Booth C, Van Houtte M, et al
    Characterization of a novel drug-resistance pattern associated with the mutations K70G and M184V in HIV-1 reverse transcriptase.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
66. VAN DER LEE MJ , Blenke AA, Rongen GA, Verwey-van Wissen CP, et al
    Combined use of paroxetine and fosamprenavir/ritonavir: an interaction study in healthy subjects.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
67. NTEMGWA M , Wainberg MA, Oliveira M, Moisi D, et al
    Variations in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Show Divergent Phenotypic Resistance to Zidovudine.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. PAINTSIL E , Dutschman GE, Hu R, Grill SP, et al
    Intracellular Metabolism and Persistence of the Anti-Human Immunodeficiency Virus Activity of 2', 3'-Didehydro-3'-Deoxy-4'- Ethynylthymidine, A Novel Thymidine Analog.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. DOYLE PS , Zhou YM, Engel JC, McKerrow JH, et al
    A Cysteine Protease Inhibitor Cures Chagas' Disease in an, Immunodeficient Murine Model of Infection.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
70. WIRE MB , Ballow CH, Borland J, Shelton MJ, et al
    Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchanged.
    Antimicrob Agents Chemother. 2007;51:2982-4.
    PubMed     Related articles    Abstract available
    
    
    July 2007
71. FLYNN PM , Rodman J, Lindsey JC, Robbins B, et al
    Intracellular Pharmacokinetics of Once vs. Twice Daily Zidovudine and Lamivudine in Adolescents.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. TONG L , Phan TK, Robinson KL, Babusis D, et al
    Effects of HIV Protease Inhibitors on the Intestinal Absorption of Tenofovir Disoproxil Fumarate in vitro.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. PAINTER GR , Almond MR, Trost LC, Lampert BM, et al
    EVALUATION OF HEXADECYLOXYPROPYL-9-R-[2-(PHOSPHONOMETHOXY)PROPYL]-ADENINE, CMX157, AS A POTENTIAL TREATMENT OF HIV-1 AND HEPATITIS B VIRUS INFECTIONS.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
74. BLAIR WS , Cao J, Jackson L, Jimenez J, et al
    Identification and Characterization of UK-201844, A Novel Inhibitor That Interferes with HIV-1 gp160 Processing.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. SMITH PF , Ogundele A, Forrest A, Wilton J, et al
    Phase I/II Study Of The Safety, Virologic Effect, And Pharmacokinetics/Pharmacodynamics Of Single Dose 3-O-(3',3'-dimethylsuccinyl) betulinic acid (Bevirimat) in HIV-Infection.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. DANDACHE S , Sevigny G, Yelle J, Stranix BR, et al
    In Vitro Antiviral Activity and Cross-Resistance Profile of PL-100, a Next Generation Protease Inhibitor of Human Immunodeficiency Virus Type 1.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. CHEN L , Sabo JP, Philip E, Mao Y, et al
    Steady-state disposition of the nonpeptidic protease inhibitor tipranavir when coadministered with ritonavir.
    Antimicrob Agents Chemother. 2007;51:2436-44.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
78. SHI M , Wang X, De Clercq E, Takao S, et al
    Selective inhibition of porcine endogenous retrovirus replication in human cells by acyclic nucleoside phosphonates.
    Antimicrob Agents Chemother. 2007;51:2600-4.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
79. BORKOW G , Sidwell RW, Smee DF, Barnard DL, et al
    Neutralizing viruses in suspensions by copper oxide-based filters.
    Antimicrob Agents Chemother. 2007;51:2605-7.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    April 2007
80. STICKNEY DR , Noveljic Z, Garsd A, Destiche DA, et al
    Safety and activity of the immune modulator HE2000 on the incidence of tuberculosis and other opportunistic infections in AIDS patients.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
81. VON HENTIG N , Muller A, Rottmann C, Wolf T, et al
    Pharmacokinetics of saquinavir, atazanavir, and ritonavir in a twice-daily boosted double-protease inhibitor regimen.
    Antimicrob Agents Chemother. 2007;51:1431-9.
    PubMed     Related articles    Abstract available   Free Full Text
    
    

Thank you for your interest in scientific medicine.

This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Boehringer Ingelheim and Pfizer.

Amedeo is a Bernd Sebastian Kamps website.    Design: